Abstract
The COVID-19 virus was first discovered from China. It has been widely spread internationally. Currently, compare with the rising trend of the overall international epidemic situation, China’s domestic epidemic situation has been contained and shows a steady and upward trend. In this situation, overseas imports have become the main channel for china to increase the number of infected people. Therefore, how to track the spread channel of international epidemics and predict the growth of overseas case imports is become an open research question. This study proposes a Gaussian sparse network model based on lasso and uses Hong Kong as an example. To explore the COVID-19 virus from a network perspective and analyzes 75 consecutive days of COV-19 data in 188 countries and regions around the world. This article establishes an epidemic spread relationship network between Hong Kong and various countries and regions around the world and build a regression model based on network information to fit Hong Kong’s COV-19 epidemic growth data. The results show that the regression model based on the relationship network can better fit the existing cumulative number growth curve. After combining the SEIJR model, we predict the future development trend of cumulative cases in Hong Kong (without blocking international traffic). Based on the prediction results, we suggest that Hong Kong can lift the international traffic blockade from early to mid-June.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Macau Science and Technology Development Funds Grands No.003/2016/AFJ and No.0055/2018/A2 from the Macau Special Administrative Region of the People’s Republic of China.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Complete List of Authors: Rui Miao: Faculty of Information Technology, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China. Email: miaorui.research{at}gmail.com
Qi Dang: Faculty of Information Technology, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China. Email: miaorui.research{at}gmail.com
Yong Liang: Faculty of Information Technology, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China. Email: miaorui.research{at}gmail.com, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China, Guangdong-HongKong-Macao Joint Laboratory for Smart Discrete Manufacturing, Guangzhou 510006, China. Email: yliang{at}must.edu.mo
Data Availability
The real epidemic data set used in this article mainly comes from the website:https://github.com/BlankerL/DXY-COVID-19-Data,Including the cumulative number of confirmed cases and cumulative number of cured cases from January 19 to April 2, 2020